Aethlon Medical’s (AEMD.OB) Hemopurifier Making Headway in Drug Therapy Care
Aethlon Medical Inc. develops therapeutic filtration devices to address infectious disease and cancer. The Medanta Independent Ethics Committee (MIEC) at the Medicity Institute (Medicity) in India recently approved a treatment program entitled: "Use of the Aethlon Hemopurifier® in Treating Chronic HCV Infection in Combination with Standard of Care (SOC) Drug Therapy." The Aethlon Hemopurifier is the first-of-its kind medical device that selectively targets the removal of infectious viruses and immunosuppressive proteins from the entire circulatory system. Aethlon said that one of the clinical goals of the Aethlon-Medicity study is to demonstrate that the Hemopurifier® can accelerate the benefit of HCV…